Cannabis Use, Medication Management and Adherence Among Persons Living with HIV

被引：0
作者：
Denise C. Vidot
Brenda Lerner
Raul Gonzalez
机构：
[1] University of Miami,School of Nursing and Health Sciences
[2] Florida International University,Department of Psychology, Center for Children and Families
来源：
AIDS and Behavior | 2017年 / 21卷
关键词：
Cannabis; Adherence; Medication management; HIV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cannabis is used to relieve nausea, trigger weight gain, and reduce pain among adults living with HIV; however, the relationship between its use and medication adherence and management is unclear. Participants (N = 107) were from an ongoing cohort study of community-dwelling HIV+ adults, stratified by cannabis (CB) use: HIV+/CB+ (n = 41) and HIV+/CB− (n = 66). CB+ participants either tested positive in a urine toxicology screen for THC or had a self-reported history of regular and recent use. HIV-status was provided by physician results and/or biomarker assessment. Adherence was measured via the Morisky scale and medication management was assessed via the Medication Management Test-Revised. After adjusting for gender, we found no association between cannabis use group and adherence nor medication management. The amount of cannabis used was also not associated with measures of adherence and management. Preliminary findings suggest that cannabis use may not adversely influence medication adherence/management among adults living with HIV.
引用
收藏
页码：2005 / 2013
页数：8
相关论文
共 208 条
  • [1] Mimiaga MJ(2013)Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort Am J Public Health 103 1457-1467
  • [2] Reisner SL(2012)Medicinal and recreational marijuana use among HIV-infected women in the Women’s Interagency HIV Study (WIHS) cohort, 1994–2010 J Acquir Immune Defic Syndr 61 618-626
  • [3] Grasso C(2007)Marijuana as therapy for people living with HIV/AIDS: social and health aspects AIDS Care. 19 295-301
  • [4] Crane HM(2013)The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS Cochrane Database Syst Rev. 5 153-168
  • [5] Safren SA(2009)Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions J Opioid Manag 34 672-680
  • [6] Kitahata MM(2009)Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial Neuropsychopharmacology. 45 545-554
  • [7] D’Souza G(2007)Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep J Acquir Immune Defic Syndr 82 1556-1563
  • [8] Matson PA(2014)Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology Neurology. 33 195-209
  • [9] Grady CD(2013)The pharmacologic and clinical effects of medical cannabis Pharmacotherapy. 313 2456-2473
  • [10] Nahvi S(2015)Cannabinoids for medical use: a systematic review and meta-analysis J Am Med Assoc 73 292-297
12345678910